Piramal Pharma Solutions Enhances Operations with New GMP Certificates
Piramal Pharma Solutions, a recognized name in the world of Contract Development and Manufacturing Organizations (CDMO), has reached a significant milestone with the recent update of its MHRA GMP certificates at the Grangemouth facility in the UK. This is a noteworthy achievement that reflects the company's unwavering dedication to quality and compliance. The certificates cover all activities conducted within the facility’s Helix building, which is central to its operations and includes testing and production laboratories.
Helix Building: A Hub of Activities
The Helix building is specifically designed to provide high-quality drug substance manufacturing and testing. It plays a crucial role in helping pharmaceutical companies ensure their products meet stringent safety and efficacy standards. The updated MHRA GMP certificates not only validate the operations within the facility but are also a testament to the successful completion of a compliance report and a thorough desktop inspection.
Strategic Commitment to Drug Development
At the heart of Piramal Pharma Solutions' operation lies its commitment to supporting partners through every stage of drug development. With the updated GMP certificates valid for three years, the Grangemouth facility is well-equipped to handle various client programs, particularly in the field of bioconjugates. This facility serves as a key player in the ADCelerate™ program, which is designed to expedite the journey of bioconjugate therapies from research and development to GMP production, ensuring that vital treatments reach patients promptly.
Expertise and Regulatory Excellence
Piramal Pharma Solutions has built a strong reputation for regulatory excellence, evidenced by a remarkable track record with agencies such as the USFDA and PMDA. Such diligence in compliance has established the Grangemouth facility not just as a compliant unit but as a leader in the pharmaceutical manufacturing sector. Peter DeYoung, CEO of Piramal Global Pharma, emphasized the importance of these updated certificates, highlighting them as vital for continuing to uphold the highest standards of quality and support the ongoing development of life-saving therapies.
About Piramal Pharma Solutions
Piramal Pharma Solutions (PPS) operates as a full-service CDMO, offering comprehensive development and manufacturing solutions throughout the drug lifecycle. Their globally integrated network, spanning North America, Europe, and Asia, allows them to provide services that encompass drug discovery, clinical trial supplies, and commercial production of APIs and finished dosage forms. The firm also focuses on niche areas, such as developing and manufacturing highly potent APIs and antibody-drug conjugates.
Strategic Impact of Piramal Pharma Limited
Piramal Pharma Limited (PPL) leverages its extensive facilities and distribution networks to deliver differentiated products and services across over 100 countries. With a strong market presence in critical care, pharmaceuticals, and even consumer healthcare products, PPL supports innovation in various therapeutic areas. Their strategic minority investment in Yapan Bio Private Limited enhances their offerings in biologics and vaccines, further solidifying their status in the rapidly evolving pharmaceutical landscape.
Frequently Asked Questions
What are MHRA GMP certificates?
MHRA GMP certificates verify that a manufacturing facility adheres to Good Manufacturing Practices, ensuring products are produced consistently and controlled to quality standards.
Why is the Grangemouth facility important for bioconjugates?
The Grangemouth facility specializes in the manufacturing of bioconjugates, providing essential services for the development of lifesaving therapies through its advanced capabilities.
How long are the new GMP certificates valid?
The updated MHRA GMP certificates at the Grangemouth facility are valid for three years, ensuring ongoing compliance and regulatory readiness.
What role does the ADCelerate™ program play?
The ADCelerate™ program is designed to streamline the process from R&D to GMP production of antibody-drug conjugates, facilitating faster delivery of therapies to patients.
What services does Piramal Pharma Solutions offer?
Piral Pharma Solutions provides a broad range of services, including drug discovery, clinical trial production, commercial manufacturing, and specialized services for highly potent APIs and biologics.
